Login / Signup

Use of the IL-6R antagonist tocilizumab in hospitalized COVID-19 patients.

Krish PatelT A GooleyN BaileyM BaileyL HegerovaA BatchelderH HoldreadV DunleavyT DowneyJ FrisvoldS MegrathK PagariganJ SzetoJ RuedaA IslamC MareeS NyatsatsangS E BorkA LipkeD S O'MahonyT WagnerJ PulidoJ MignoneS YoussefM HartmanJ D GoldmanJ M Pagel
Published in: Journal of internal medicine (2020)
Keyphrases
  • rheumatoid arthritis
  • sars cov
  • juvenile idiopathic arthritis
  • rheumatoid arthritis patients
  • disease activity